[1]
Gürhan KADIKÖYLÜ et al. 2020. The Prevalance of Anti-Hepatitis C Virus in Patients with Hepatocellular Carcinoma. Turkish Journal of Gastroenterology. 4, 2 (Apr. 2020), 269–271.